MRNA Jan 2025 165.000 call
| Previous Close | 28.55 |
| Open | 31.96 |
| Bid | 29.55 |
| Ask | 31.55 |
| Strike | 165.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 30.60 - 32.90 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 549 |
Barrons.comCancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
The American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual meeting. Companies such as GSK, Moderna, BioNTech, Gilead, and many others will reporting their progress.
ZacksVaccine Stocks Rise on Growing Threat of Bird Flu Infections
The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.
BloombergSecond US Human Bird Flu Infection Reported in Michigan
(Bloomberg) -- A Michigan farmworker tested positive with bird flu, the second person to contract the potentially lethal virus that has run rampant in US cattle.Most Read from BloombergNvidia Stock Surges as Sales Forecast Delivers on AI HopesThese Flight Routes Suffer the World’s Worst TurbulenceCiti Trader Got 711 Warning Messages Before Sparking Flash CrashHarvard Defies Faculty Vote to Block 13 Students From GraduatingUS Justice Department to Seek Breakup of Live Nation-TicketmasterThe farmw
